BioLineRx, Israel’s Biotech Incubator, Nearing Major Inflection Points
This article was originally published in The Pink Sheet Daily
Executive Summary
Funded in part by the Israeli government, BioLineRx believes it is about to score big with a cardiology drug being developed under FDA’s regulatory pathway for devices, as well as a schizophrenia candidate that could improve patients’ cognition.